trending Market Intelligence /marketintelligence/en/news-insights/trending/f13szcvvsqiqdmbaaz-xcw2 content esgSubNav
In This List

BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

BioSig Technologies Inc. said it will implement a 1-for-2.5 reverse split of its common stock after the close of business Sept. 10 to meet requirements for its Nasdaq uplisting.

The Los Angeles-based development stage medical device company said its stock will begin trading on a split-adjusted basis from Sept. 11.

The reverse split was approved by BioSig's stockholders July 30.

BioSig's first product, the PURE EP System, which records and calculates electrocardiographic and intracardiac signals, among other things, for patients undergoing electrophysiology procedures in a laboratory, was approved by the U.S. Food and Drug Administration in August.